Oxycodone was clastogenic while in the human lymphocyte chromosomal assay while in the presence of metabolic activation and in the mouse lymphoma assay with or without metabolic activation.After stopping a CYP3A4 inducer, given that the effects on the inducer decline, the oxycodone plasma focus will boost [see CLINICAL PHARMACOLOGY], which could in